Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Prepaid Assets (2019 - 2026)

Atea Pharmaceuticals' Prepaid Assets history spans 8 years, with the latest figure at $7.2 million for Q1 2026.

  • Quarterly Prepaid Assets fell 13.07% to $7.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $7.2 million through Mar 2026, down 13.07% year-over-year, with the annual reading at $9.2 million for FY2025, 20.0% up from the prior year.
  • Prepaid Assets came in at $7.2 million for Q1 2026, down from $9.2 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $14.2 million in Q4 2022 to a low of $4.1 million in Q3 2024.
  • The 5-year median for Prepaid Assets is $7.7 million (2022), against an average of $8.5 million.
  • Year-over-year, Prepaid Assets surged 278.76% in 2022 and then tumbled 67.45% in 2024.
  • Atea Pharmaceuticals' Prepaid Assets stood at $14.2 million in 2022, then dropped by 13.11% to $12.3 million in 2023, then plummeted by 38.18% to $7.6 million in 2024, then grew by 20.0% to $9.2 million in 2025, then dropped by 21.5% to $7.2 million in 2026.
  • Per Business Quant, the three most recent readings for AVIR's Prepaid Assets are $7.2 million (Q1 2026), $9.2 million (Q4 2025), and $6.8 million (Q3 2025).